Cell Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-08-03
Clinical Trial Update: Ruxolitinib Plus LVP in Patients With R/R ETP-ALL [Phase 1, Phase 2]
Clinical trial update for ruxolitinib plus LVP in relapsed/refractory early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) spanning…